Found 0 matching trials
On Demand Contraception: Ulipristal Acetate Plus a COX-2 Inhibitor at Peak Fertility PHASE1 This is an exploratory prospective study investigating if addition of a COX...
Show More Location
Stanford University
Learn More & Join Trial
Efficacy Study of Two Continuous Regimens of Oral Daily 5 mg or 10 mg of Ulipristal Acetate (UPA), Versus a Dose of 5.0mg UPA for 24/4 Days PHASE2 To compare the pharmacodynamic effects of 2 continuous dose regimens of uli...
Show More Location
California Family Health Council
Learn More & Join Trial
Ovarian Function With ENG Implant and UPA Use EARLY_PHASE1 Same day initiation of the etonogestrel (ENG) implant and oral ulipristal a...
Show More Location
University of Utah
Learn More & Join Trial
Study of Ulipristal Acetate in Female Patients With Moderately or Severely Impaired Renal Function, Compared With Matched Healthy Female Subjects PHASE1 This study is designed to observe the effect of renal function on the pharm...
Show More Location
Division of Clinical Pharmacology, University of Miami
Learn More & Join Trial
Esmya Versus Surgery Before IVF/ICSI N/A Studying the possible outcome differences between surgery or medical treatm...
Show More Location
Universitair Ziekenhuis UZBrussel
Learn More & Join Trial
Quality of Life Outcomes for Ulipristal Acetate and Tranexamic Acid in the Management of Heavy Menstrual Bleeding PHASE1 This study compares two treatments for the management of heavy menstrual bl...
Show More Location
Saskatoon Obstetric and Gynecologic Consultants
Learn More & Join Trial
Effectiveness of Orally Dosed Emergency Contraception in Obese Women - UPA PHASE4 Obese women are significantly more likely than their normal BMI counterpart...
Show More Learn More & Join Trial
Adenomyosis and Ulipristal Acetate PHASE2 Evaluation of efficiency of selective progesterone receptor modulators (SPR...
Show More Location
AP-HP, Bicêtre Hospital
Learn More & Join Trial
A proof-of Concept, Randomized 3-month Study to Evaluate the Effects of Three Contraceptive Intrauterine Systems Delivering Copper and a Daily Dose of 5, 20 or 40 μg of Ulipristal Acetate (UPA) PHASE1 The UPA doses to be tested in this new IUS, 5, 20 or 40 μg per day, are not...
Show More Learn More & Join Trial
PGL4001 Versus GnRH-agonist in Uterine Myomas PHASE3 This trial will assess the efficacy and safety of PGL4001 versus GnRH agoni...
Show More Location
Medical University Graz
Learn More & Join Trial